|4Jun 27, 4:20 PM ET

Gabay Avraham 4

4 · ORAMED PHARMACEUTICALS INC. · Filed Jun 27, 2019

Insider Transaction Report

Form 4
Period: 2019-06-17
Gabay Avraham
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-06-17+33,14633,146 total
    Exercise: $3.55Exp: 2029-06-17Common Stock (33,146 underlying)
Footnotes (1)
  • [F1]The Stock Option will vest in 4 installments as follows: 5,396 shall vest on December 31, 2019; and 9,250 shall vest on each of December 31, 2020, December 31, 2021 and December 31, 2022.

Documents

1 file
  • 4
    ownership.xmlPrimary